Free Trial

Genus (LON:GNS) Sets New 12-Month Low - What's Next?

Genus logo with Medical background

Genus plc (LON:GNS - Get Free Report) hit a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 1,478 ($18.53) and last traded at GBX 1,499.40 ($18.80), with a volume of 1890597 shares changing hands. The stock had previously closed at GBX 1,514 ($18.98).

Wall Street Analysts Forecast Growth

Separately, Shore Capital restated a "buy" rating on shares of Genus in a research note on Wednesday, December 11th.

Check Out Our Latest Research Report on Genus

Genus Stock Up 0.4 %

The company has a current ratio of 1.80, a quick ratio of 1.08 and a debt-to-equity ratio of 53.54. The company has a market capitalization of £996.66 million, a PE ratio of 12,666.67, a PEG ratio of 2.87 and a beta of 0.37. The business has a fifty day moving average of GBX 1,839.27 and a 200 day moving average of GBX 1,810.62.

Genus Company Profile

(Get Free Report)

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.

Read More

→ 3 golden rules for dividends (From Jack Carter Trading) (Ad)

Should you invest $1,000 in Genus right now?

Before you consider Genus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genus wasn't on the list.

While Genus currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Unveils Game-Changing Tech, But Stock Dips
Rivian Stock Surge Analysis: Long-Term Potential or Short-Term Play?
The Future of Healthcare: 3 AI Stocks Leading the Way

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines